Controlling ischemic cardiovascular disease: From basic mechanisms to clinical management

Annals of the New York Academy of Sciences

Volumn 1123, Issue , 2008, Pages 232-236

  Beyar, Rafael ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Rambam Health Care Campus ^*  (Israel)

Author keywords

Coronary stenosis; Heart failure; Ischemic heart disease; Myocardial damage

Indexed keywords

PACLITAXEL; RAPAMYCIN;

BYPASS SURGERY; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; EXTRACORPOREAL CIRCULATION; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; POPULATION GENETICS; RESTENOSIS;

EID: 41149137146     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1420.026     Document Type: Conference Paper

References (41)

1. LOPEZ, A.D., C.D. MATHERS, et al. 2006. Global and regional burden of disease and risk factors, systematic analysis of population health data. Lancet 367: 1747-1757.
2. O'FLAHERTY, M.E., E.S. FORD, et al. 2007. Coronary heart disease trends in England and Wales from 1984 to 2004: concealed leveling of mortality rates among young adults. Heart. In press.
3. FORD, E.S., U.A. AJANI, J.B. CROFT, et al. 2007. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N. Engl. J. Med. 356: 2388-2398.
4. DAEMEN, J., P.W. SERRUYS. 2006. Optimal revascularization strategies for multivessel coronary artery disease. Curr. Opin. Cardiol. 21: 595-601.
5. ROUBIN, G. & A. GRÜNTZIG. 1986. The coronary artery bypass surgery-angioplasty interface. Cardiology 73: 269-277.
6. WEISZ, G. & J.W. MOSES. 2007. New percutaneous approaches for chronic total occlusion of coronary arteries. Expert Rev. Cardiovasc. Ther. 5: 231-241.
7. SURMELY, J.F., E. TSUCHIKANE, et al. 2006. New concept for CTO recanalization using controlled antegrade and retrograde subintimal tracking: the CART technique. J. Invasive Cardiol. 18: 334-338.
8. HOYE, A., P.A. LEMOS & P.W. SERRUYS. 2005. Successful use of a new guidewire with radiofrequency ablation capability for the treatment of chronic total occlusion at the ostium of the left anterior descending artery. J. Invasive Cardiol. 17: 277-279.
9. TOPOL, E.J. & S.E. NISSEN. 1995. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 92: 2333-2342.
10. TSETIS, D., R. MORGAN & A.M. BELLI. 2006. Cutting balloons for the treatment of vascular stenosis. Eur. Radiol. 16: 1675-1683.
11. HONDA, Y. & P.J. FITZGERALD. 2001. The renaissance of directional coronary atherectomy: a second look from the inside. J. Invasive Cardiol. 13: 748-751.
12. REITH, S., P.W. RADKE, O. VOLK, et al. 2000. The place of rotablator for treatment of in-stent restenosis. Semin. Interv. Cardiol. 5: 199-208.
13. KOSTER, R., J. KAHLER, et al. 2002. Laser coronary angioplasty: history, present and future. Am. J. Cardiovasc. Drugs 2: 197-207.
14. KOSTER, R., C.W. HAMM, et al. 1999. Laser angioplasty of restenosed coronary stents: results of a multicenter surveillance trial. J. Am. Coll. Cardiol. 34: 25-32.
15. HOLMES, D.R. JR., J. HIRSHFELD, JR. et al. 1998. ACC expert consensus document on coronary artery stents: document of the American College of Cardiology. J. Am. Coll. Cardiol. 32: 1471-1482.
16. BHODAY, J., S. DE SILVA & Q. XU. 2006. The molecular mechanisms of vascular restenosis: Which genes are crucial? Curr. Vasc. Pharmacol. 4: 269-275.
17. GASPARDONE, A. & F. VERSACI. 2005. Coronary stenting and inflammation. Am. J. Cardiol. 96: 65L-70L.
18. NIKOLSKY, E., E. ROSENBLATT, E. GRENADIER, et al. 2002. A prospective single-center registry for the use of intracoronary gamma radiation in patients with diffuse instent restenosis. Catheter. Cardiovasc. Interv. 56: 46-52.
19. MORICE, M.C., P.W. SERRUYS, et al. 2002. RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med. 346: 1773-1780.
20. LEMOS, P.A., A. HOYE, D. GOEDHART, et al. 2004. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients - An evaluation from the Rapamycin-Eluting Stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 109: 1366-1370.
21. DAEMEN, J. & P.W. SERRUYS. 2007. Drug-eluting stent update 2007: part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same? Circulation 116: 316-328.
22. LINDT, R., F. VOGT, I. ASTAFIEVA, et al. 2006. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J. Am. Coll. Cardiol. 47: 1786-1795.
23. EELEY, E.C., & L.D. HILLIS. 2007. Primary PCI for myocardial infarction with ST-segment elevation. N. Engl. J. Med. 356: 47-54.
24. BASSO, C. & G. THIENE. 2006. The pathophysiology of myocardial reperfusion: a pathologist's perspective. Heart 92: 1559-1562.
25. GROSS, G.J. & J.A. AUCHAMPACH. 2007. Reperfusion injury: does it exist? J. Mol. Cell. Cardiol. 42: 12-18.
26. DUPLAIN, H. 2006. Salvage of ischemicmyocardium: a focus on JNK. Adv. Exp. Med. Biol. 588: 157-164.
27. LY, H.Q., A. DENAULT, J. DUPUIS, et al. 2005. A pilot study: the noninvasive surface cooling thermoregulatory system for mild hypothermia induction in acute myocardial infarction (the NICAMI Study). Am. Heart J. 150: 933.
28. DOBERT, N., M. BRITTEN, et al. 2004. Related transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur. J. Nucl. Med. Mol. Imaging 31: 1146-1151.
29. SHIN, D.D., F. BRANDIMARTE, et al. 2007. Review of current and investigational pharmacologic agents for acute heart failure syndromes. Am. J. Cardiol. 99: 4A-23A.
30. APAIOANNOU, T.G. & C. STEFANADIS. 2005. Basic principles of the intraaortic balloon pump and mechanisms affecting its performance. ASAIO J. 51: 296-300.
31. BIRKS, E.J., P.D. TANSLEY, et al. 2006. Left ventricular assist device and drug therapy for the reversal of heart failure. N. Engl. J. Med. 355: 1873-1884.
32. GRAY, N.A. JR. & C.H. SELZMAN. 2006. Current status of the total artificial heart. Am. Heart J. 152: 4-10.
33. JOLICOEUR, E.M., C.B. GRANGER, et al. 2007. National Heart, Lung, and Blood Institute Cell Therapy Working Group Members. Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting. Am. Heart J. 153: 732-742.
34. WOLLERT, K.C. & H. DREXLER. 2005. Clinical applications of stem cells for the heart. Circ. Res. 96: 151-163.
35. KEHAT, I., D. KENYAGIN-KARSENTI, et al. 2001. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108: 407-414.
36. KEHAT, I., L. KHIMOVICH, et al. 2004. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22: 1282-1289.
37. CASPI, O., A. LESMAN, et al. 2007. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 100: 263-272.
38. SULEIMAN, M., D. ARONSON, et al. 2005. Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. Diabetes 54: 2802-2806.
39. FERRARI, M., H. MUDRA, L. GRIP, et al. 2002. OPTICUS ACE Substudy. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation. Cardiology 97: 29-36.
40. KOCH, W., A. KASTRATI, J. MEHILLI, et al. 2000. A. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation 102: 197-202.
41. SAMANI, N.J., J. ERDMANN, A.S. HALL, et al. 2007. Genomewide association analysis of coronary artery disease. N. Engl. J.Med. 357: 443-453.